600299.SHG Bluestar Adisseo Co
- Market cap
- CNY 26.1B
- P/E
- 14.1x
- P/B
- 1.29x
- ROE
- 11.0%
- Dividend yield
- 2.21%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 600299.SHG undervalued?
Graham number600299.SHG trades 10.0% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Bluestar Adisseo Co fundamental analysis
No fundamental analysis for Bluestar Adisseo Co yet.
Bluestar Adisseo Co stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Bluestar Adisseo Co
Bluestar Adisseo Company, together with its subsidiaries, engages in the research, development, production, and sale of poultry, ruminant, swine, and aquaculture nutrition additives. The company also offers mycotoxin management and palatability comprising, Unike Plus, Unike, Oxy-Nil, Mold-Nil, Salmo-Nil, Toxy-Nil, Krave AP, Optisweet, Gusti Plus, Maxarome, Delistart, Pepsea, Nutri-Bind Aqua, and Oxy-Nil Aqua Zero; enzymes and emulsifiers, including Rhodimet AT88 and Rhodimet…
Full company profileBluestar Adisseo Co financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Bluestar Adisseo Co annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 10.7B | 10.4B | 11.4B | 11.1B | 11.9B | 12.9B | 14.5B | 13.2B | 15.5B | 17.2B | 20.4B |
| Gross Profit | 5.04B | 4.06B | 3.97B | 3.78B | 4.51B | 4.39B | 3.90B | 2.81B | 4.67B | 4.88B | 6.18B |
| Operating Income | 3.19B | 2.38B | 1.67B | 1.59B | 2.05B | 2.06B | 1.50B | 68.4M | 1.73B | 1.68B | 3.19B |
| EBITDA | 4.01B | 3.04B | 2.68B | 2.47B | 3.26B | 3.25B | 2.90B | 1.90B | 3.20B | 3.20B | 3.02B |
| Net Income | 1.87B | 1.32B | 926M | 992M | 1.35B | 1.47B | 1.25B | 52.2M | 1.20B | 1.15B | 2.22B |
| EPS | 0.70 | 0.49 | 0.35 | 0.37 | 0.50 | 0.55 | 0.46 | 0.02 | 0.45 | 0.43 | 0.72 |
| Balance Sheet | |||||||||||
| Total Assets | 19.9B | 21.3B | 21.5B | 21.1B | 20.6B | 20.9B | 21.3B | 21.5B | 22.3B | 27.8B | 28.9B |
| Total Liabilities | 4.06B | 4.07B | 4.05B | 3.91B | 5.19B | 5.48B | 6.39B | 6.45B | 6.69B | 7.90B | 8.59B |
| Shareholders' Equity | 12.1B | 13.2B | 13.6B | 13.8B | 14.0B | 14.1B | 14.9B | 15.0B | 15.5B | 19.9B | 20.3B |
| Cash & Short-term Investments | 6.68B | 7.66B | 5.28B | 5.30B | 2.77B | 2.11B | 796M | 1.01B | 1.27B | 4.27B | 4.58B |
| Total Debt | 132M | 97.7M | 166M | 187M | 927M | 1.07B | 2.26B | 2.06B | 1.29B | 1.90B | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 3.05B | 2.51B | 1.44B | 2.55B | 2.71B | 2.60B | 1.73B | 2.76B | 2.94B | 3.33B | - |
| Capital Expenditure | 603M | 966M | 1.26B | 1.24B | 1.32B | 2.31B | 1.54B | 1.45B | 1.62B | 3.70B | 2.03B |
| Free Cash Flow | 2.45B | 1.55B | 178M | 1.31B | 1.39B | 288M | 187M | 1.32B | 1.32B | -372M | 397M |
| Ratios | |||||||||||
| ROE | 15.4% | 10.1% | 6.8% | 7.2% | 9.7% | 10.4% | 8.3% | 0.3% | 7.7% | 5.8% | 11.0% |
| ROA | 9.4% | 6.2% | 4.3% | 4.7% | 6.6% | 7.0% | 5.8% | 0.2% | 5.4% | 4.2% | 7.7% |
| Net Profit Margin | 17.5% | 12.7% | 8.1% | 8.9% | 11.3% | 11.4% | 8.6% | 0.4% | 7.8% | 6.7% | 10.9% |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.07x | 0.08x | 0.15x | 0.14x | 0.08x | 0.10x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Bluestar Adisseo Co dividends
- Dividend yield
- 2.21%
- Forward dividend
- 0.15 CNY
- Payout ratio
- 50.1%
- Ex-dividend date
- Jul 10, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 578M | 0.22 | 50.1% |
| 2024 | CNY 282M | 0.11 | 23.4% |
| 2023 | CNY 525M | 0.20 | 1,007.1% |
| 2022 | CNY 539M | 0.20 | 43.2% |
| 2021 | CNY 472M | 0.18 | 32.1% |
| 2020 | CNY 418M | 0.16 | 31.0% |
| 2019 | CNY 740M | 0.28 | 74.6% |
| 2018 | CNY 481M | 0.18 | 51.9% |
| 2017 | CNY 628M | 0.23 | 47.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.3:1 on Jun 13, 2008.
Who owns Bluestar Adisseo Co
- Insiders 75.41%
- Institutions 5.50%
- Public & others 19.10%
- Shares outstanding 3.08B
- Free float 779M
Bluestar Adisseo Co company profile
- Company name
- Bluestar Adisseo Co
- Ticker
- 600299.SHG
- ISIN
- CNE000001253
- Exchange
- Shanghai Stock Exchange
- Listed since
- Mar 31, 2000
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 3,295
- Fiscal year end
- December
- Address
- No. 9 West Beitucheng Road, Beijing, China, 100029
- Phone
- 86 10 6195 8802
- Website
- adisseo.com
About Bluestar Adisseo Co
Bluestar Adisseo Company, together with its subsidiaries, engages in the research, development, production, and sale of poultry, ruminant, swine, and aquaculture nutrition additives. The company also offers mycotoxin management and palatability comprising, Unike Plus, Unike, Oxy-Nil, Mold-Nil, Salmo-Nil, Toxy-Nil, Krave AP, Optisweet, Gusti Plus, Maxarome, Delistart, Pepsea, Nutri-Bind Aqua, and Oxy-Nil Aqua Zero; enzymes and emulsifiers, including Rhodimet AT88 and Rhodimet; antioxidants and health by nutrition products, comprising Rhodimet AT88, Rhodimet NP99, Microvit A Supra 1000, and Microvit E Promix 50; milk production product, such as MetaSmart; and sulfur-based products, which includes Rhodimet AT88, Rhodimet® NP99, Microvit A Supra 1000, and Microvit E Promix 50. In addition, the company offers mycotoxin management products, such as Unike Plus, Unike, Toxy-Nil, Krave AP, Optisweet, Gusti Plus, Maxarome, and Delistart, as well as essential nutrient products, such as Rhodimet AT88, a hydroxy-methionine in liquid form; and Microvit A Supra 1000 to deliver performance; Microvit E Promix 50, a specialized nutritional supplement of vitamin E; and AdiSodium, which helps monogastrics to livestock management. Further, it provides various services consisting of PNE, a near infra-red spectroscopy technology; MYCOMAN for the management of mycotoxins; ADICT, a nutritional values calculation tool; Predictor, a tool to help extract the value from feed; E.lab, a broad range of laboratory analyses to help feed and premix producers control the quality of raw materials and additives; DIM, a full support program; MilkPay calculator; Milk$MART; and NESTOR, which is used to formulate net energy. It operates in China, Europe, the Middle East, Africa, the Indian subcontinent, North and south America, the Asia-Pacific regions. The company was founded in 1939 and is based in Beijing, China. Bluestar Adisseo Company operates as a subsidiary of China National Bluestar (Group) Co,Ltd.
Bluestar Adisseo Co management
5- Dr. Zhigang HaoChief Executive Officer · born 1978
- Mr. Frederic JacquinCOO & Deputy GM · born 1967
- Ms. Yun CaiSecretary to the Board · born 1974
- Mr. Jean-François RousDeputy General Manager · born 1967
- Mr. Bing Jing DingDeputy General Manager · born 1982